Pressurized oxygen may calm PTSD symptoms
NCT ID NCT03466554
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen therapy) can help adults with PTSD from combat or terror. Thirty people who had PTSD for at least 4 years and hadn't improved with standard treatments received 60 daily sessions. Researchers used brain scans and questionnaires to measure changes in symptoms, sleep, and thinking.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber)
- What this could lead to
- If it works, this could offer a new way to ease PTSD symptoms like nightmares and avoidance, especially for people who haven't improved with standard treatments.
- What could go wrong
- This was a small early study with only 30 people and no placebo group, so results may not be reliable. HBOT also carries risks like ear pain or oxygen toxicity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Mar 2018
- Finished
-
Sep 2019
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 60 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult onset PTSD, defined by DSM-V criteria, as a result of combat or a terror- related event. * Age 25-60 years, 4-years or more from the traumatic event and failure to improve with at least one line of conventional treatment. Exclusion Criteria: * A history of traumatic brain injury, epilepsy, a brain tumor; skull base fractures or neurosurgery. * Severe substance use disorders a current manic episode, psychotic disorders or serious suicidal ideation at baseline. * Major cognitive deficits * History of HBOT for any reason, prior to study enrollment. * Chest pathology incompatible with pressure changes (including active asthma). * Inner ear disease. * The inability to perform an awake brain MRI test. * Inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assaf-Harofeh Medical Center
Ẕerifin, 70300, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized mix of nerve stimulation and therapy rewire the brain for better mental health?
- Can a therapist on a screen ease both trauma and pain?
- Zapping the Brain's fear hub: a new hope for PTSD?
- Can a drug combo or therapy dogs ease PTSD?
- Can six short writing sessions ease PTSD in underserved patients?
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?